Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EGb 761 in Cognitive Impairment in MS
NCT00276341Phase 3Completed
- Sponsor
- Ipsen
- Start
- Aug 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ginkgo biloba in cognitive impairment, sponsored by Ipsen. Started Aug 2003; status: completed.
02
Drugs
ginkgo biloba
03
Conditions
cognitive impairment
Beyond the preview
Go deeper on NCT00276341.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00276341.